- Type / Class
- Equity / Common Stock
- Shares outstanding
- 29,067,614
- Total 13F shares
- 20,961,146
- Share change
- -202,960
- Total reported value
- $1,660,575,264
- Put/Call ratio
- 688%
- Price per share
- $79.22
- Number of holders
- 153
- Value change
- -$15,716,124
- Number of buys
- 79
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7.2%
|
2,106,429
|
$146,818,000 | — | 30 Sep 2022 | |
| Redmile Group, LLC |
13F
|
Company |
6.5%
|
1,899,545
|
$132,398,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
1,565,305
|
$109,101,000 | — | 30 Sep 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.4%
|
1,275,000
|
$88,868,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4.3%
|
1,258,505
|
$87,718,000 | — | 30 Sep 2022 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
4.2%
|
1,211,941
|
$84,473,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
1,096,132
|
$76,400,000 | — | 30 Sep 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.5%
|
1,018,388
|
$70,982,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
994,144
|
$69,292,000 | — | 30 Sep 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.5%
|
724,202
|
$50,477,000 | — | 30 Sep 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.3%
|
678,470
|
$47,289,000 | — | 30 Sep 2022 | |
| Artal Group S.A. |
13F
|
Company |
1.7%
|
500,000
|
$34,850,000 | — | 30 Sep 2022 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.7%
|
492,555
|
$34,331,000 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
422,185
|
$29,426,000 | — | 30 Sep 2022 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.4%
|
416,756
|
$29,048,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
399,262
|
$27,828,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
358,837
|
$25,012,000 | — | 30 Sep 2022 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1%
|
303,599
|
$21,161,000 | — | 30 Sep 2022 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
1%
|
297,610
|
$20,743,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.83%
|
242,693
|
$16,916,000 | — | 30 Sep 2022 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.78%
|
225,809
|
$15,739,000 | — | 30 Sep 2022 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.76%
|
222,026
|
$15,475,000 | — | 30 Sep 2022 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.71%
|
207,332
|
$14,451,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
202,238
|
$14,097,000 | — | 30 Sep 2022 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.6%
|
175,000
|
$12,198,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
156,271
|
$10,893,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.49%
|
142,385
|
$9,924,000 | — | 30 Sep 2022 | |
| S Squared Technology, LLC |
13F
|
Company |
0.37%
|
108,215
|
$7,543,000 | — | 30 Sep 2022 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.36%
|
104,900
|
$7,312,000 | — | 30 Sep 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
0.32%
|
92,609
|
$6,455,000 | — | 30 Sep 2022 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.31%
|
90,000
|
$6,273,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.29%
|
85,325
|
$5,947,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
84,786
|
$5,908,000 | — | 30 Sep 2022 | |
| Verition Fund Management LLC |
13F
|
Company |
0.23%
|
67,652
|
$4,715,000 | — | 30 Sep 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.22%
|
64,786
|
$4,516,000 | — | 30 Sep 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.22%
|
64,186
|
$4,473,764 | — | 30 Sep 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
58,300
|
$4,064,000 | — | 30 Sep 2022 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
56,645
|
$3,948,000 | — | 30 Sep 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
52,256
|
$3,642,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
51,608
|
$3,597,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.17%
|
49,818
|
$3,472,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
47,313
|
$3,299,000 | — | 30 Sep 2022 | |
| Monarch Partners Asset Management LLC |
13F
|
Company |
0.16%
|
46,494
|
$3,241,000 | — | 30 Sep 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.15%
|
45,000
|
$3,132,000 | — | 30 Sep 2022 | |
| CWM, LLC |
13F
|
Company |
0.15%
|
43,384
|
$3,024,000 | — | 30 Sep 2022 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
42,600
|
$2,969,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
41,362
|
$2,883,000 | — | 30 Sep 2022 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.14%
|
40,656
|
$2,834,000 | — | 30 Sep 2022 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.12%
|
33,462
|
$2,332,000 | — | 30 Sep 2022 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.12%
|
33,439
|
$2,331,000 | — | 30 Sep 2022 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q4 2022
As of 31 Dec 2022,
Krystal Biotech, Inc. - Common Stock (KRYS) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,961,146 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, BlackRock Inc., Avoro Capital Advisors LLC, LORD, ABBETT & CO. LLC, VANGUARD GROUP INC, STATE STREET CORP, Frazier Life Sciences Management, L.P., CREDIT SUISSE AG/, and PICTET ASSET MANAGEMENT SA.
This page lists
153
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
141
Q4 2022 holders
153
Holder diff
12
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.